BALs are prognostic biomarkers and correlate with malignant behaviors in breast cancer
These findings suggest that both BAL1 and BAL2 hold great potential as significant prognostic biomarkers and therapeutic targets for patients with BC.
Authors
- Bingqiang Zhang (ORCID: https://orcid.org/0000-0002-9149-3677)
- Xuehao Zhou
- Mengmeng Chen (ORCID: https://orcid.org/0000-0003-4179-0427)
- Qingling Xu (ORCID: https://orcid.org/0000-0003-4333-4214)
- Xiang Ao (ORCID: https://orcid.org/0000-0003-2568-8166)
- Ying Liu (ORCID: https://orcid.org/0000-0001-9356-5622)
- Yu Wang (ORCID: https://orcid.org/0000-0002-9029-1846)
Institutions
- Qingdao University (CN)
- Shanghai Jiao Tong University (CN)
- Affiliated Hospital of Qingdao University (CN)
- Shanghai First People's Hospital (CN)
- Qingdao Center of Resource Chemistry and New Materials (CN)
Publication Details
- Journal
- BMC Cancer
- Published
- 2025-07-24
- DOI
- https://doi.org/10.1186/s12885-025-14576-0
- Primary Topic
- PARP inhibition in cancer therapy
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Natural Science Foundation of Shandong Province